Investors

Your browser does not support iframes.

News Release

View All

September 17, 2024

RELEASE OF DEMENTIA DISEASE AWARENESS VIDEO FOR WORLD ALZHEIMER鈥橲 MONTH
鈥淭ODAY FOR TOMORROW鈥�: A DOCUMENTARY OF SIX MONTHS FOLLOWING THE CURRENT STATE OF DEMENTIA
鈥淟EARNING HELPS US TO BE KIND鈥�
September 17, 2024

LENVIMA庐 (lenvatinib) Plus KEYTRUDA庐 (pembrolizumab) in Combination With Transarterial Chemoembolization (TACE) Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma
In the Phase 3 LEAP-012 trial, LENVIMA plus KEYTRUDA in combination with TACE reduced the risk of disease progression or death by 34% compared to TACE alone

Late-breaking first interim analysis results are being presented during a Presidential Symposium session at the European Society for Medical Oncology Congress 2024
September 12, 2024

Investigator-initiated clinical studies to be launched following confirmation of tumor shrinkage induced by the targeted protein degrader E7820 using J-PDX (Japanese cancer patient-derived tissue transplantation models)
Aiming to establish a drug discovery and development system that accelerates the development of new anticancer drugs
September 5, 2024

EISAI ACCELERATES PROGRESS IN ONCOLOGY RESEARCH WITH NEW DATA AT ESMO CONGRESS 2024
September 2, 2024

乌鸦传媒 Announces Status Relating to Acquisition of Own Shares
Acquisition of own shares pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act

Latest Financial Reports

Consolidated Financial Report for First Quarter Financial Results for the Fiscal Year Ending March 31, 2025

乌鸦传媒

News Release

Latest Financial Reports

Financial Information

Latest Presentations

Electronic Public Notice

Management Policy

IR Library

Financial Data

IR Events & Calendar

Stock & Bond Information

Other